Floatz logo

Nanocrystalline Megestrol Acetate Suspension

Extensive-stage Small Cell Lung Cancer (ES-SCLC)

Guangzhou Institute of Respiratory DiseasePhase 2Active
CCC
53/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
38/ 100
Competitive Position
89/ 100

Competitive context

290 Active assets in the Extensive-stage Small Cell Lung Cancer (ES-SCLC) cohort.

Asset / SponsorPhaseRating
Benmelstobart
Yayi He
Phase 4A
vx-970
National Cancer Institute (NCI)
Phase 2BBB
Adebelimab
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Phase 3BBB
Veliparib
Central European Society for Anticancer Drug Research
Phase 2BB
CIS-DIAMMINEDICHLOROPLATINUM II
National Cancer Institute (NCI)
Phase 4BB

View all 50 →

Same molecule, other indications

Nanocrystalline Megestrol Acetate Suspension is also rated in:

CachexiaDormant
BB
Indicative ·
64 / 100
View asset →
hepatocellular carcinomaDormant
B
Indicative ·
56 / 100
View asset →
nutritional deficiency diseaseDormant
CCC
Indicative ·
53 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →